JP2012526769A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012526769A5 JP2012526769A5 JP2012510286A JP2012510286A JP2012526769A5 JP 2012526769 A5 JP2012526769 A5 JP 2012526769A5 JP 2012510286 A JP2012510286 A JP 2012510286A JP 2012510286 A JP2012510286 A JP 2012510286A JP 2012526769 A5 JP2012526769 A5 JP 2012526769A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- cycloalkyl
- acceptable salt
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17868009P | 2009-05-15 | 2009-05-15 | |
| US61/178,680 | 2009-05-15 | ||
| US32722110P | 2010-04-23 | 2010-04-23 | |
| US61/327,221 | 2010-04-23 | ||
| PCT/EP2010/056529 WO2010130773A2 (en) | 2009-05-15 | 2010-05-12 | Benzoxazolone derivatives as aldosterone symthase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012526769A JP2012526769A (ja) | 2012-11-01 |
| JP2012526769A5 true JP2012526769A5 (OSRAM) | 2013-06-20 |
| JP5654572B2 JP5654572B2 (ja) | 2015-01-14 |
Family
ID=42938295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012510286A Expired - Fee Related JP5654572B2 (ja) | 2009-05-15 | 2010-05-12 | アルドステロンシンターゼ阻害剤としてのベンズオキサゾロン誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8455522B2 (OSRAM) |
| EP (1) | EP2430018B1 (OSRAM) |
| JP (1) | JP5654572B2 (OSRAM) |
| KR (1) | KR20120036850A (OSRAM) |
| CN (1) | CN102459247B (OSRAM) |
| AU (1) | AU2010247391A1 (OSRAM) |
| BR (1) | BRPI1012852A2 (OSRAM) |
| CA (1) | CA2761853A1 (OSRAM) |
| EA (1) | EA201101621A1 (OSRAM) |
| ES (1) | ES2430088T3 (OSRAM) |
| MX (1) | MX2011012199A (OSRAM) |
| WO (1) | WO2010130773A2 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2430088T3 (es) | 2009-05-15 | 2013-11-18 | Novartis Ag | Derivados de benzoxazolona como inhibidores de aldosterona sintasa |
| US8778972B2 (en) | 2009-05-15 | 2014-07-15 | Novartis Ag | 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or CYP11B1 |
| MY184008A (en) * | 2009-05-15 | 2021-03-17 | Novartis Ag | Aryl pyridine as aldosterone synthase inhibitors |
| EP2501678B1 (en) * | 2009-11-17 | 2015-09-23 | Novartis AG | Aryl-pyridine derivatives as aldosterone synthase inhibitors |
| EP2755963B1 (en) | 2011-09-15 | 2019-10-30 | F.Hoffmann-La Roche Ag | New dihydroquinoline-2-one derivatives |
| KR102417686B1 (ko) | 2016-04-20 | 2022-07-07 | 브리스톨-마이어스 스큅 컴퍼니 | 치환된 비시클릭 헤테로시클릭 화합물 |
| KR102530512B1 (ko) | 2016-11-03 | 2023-05-08 | 브리스톨-마이어스 스큅 컴퍼니 | Romk 채널 억제제로서 유용한 치환된 비사이클 헤테로시클릭 유도체 |
| BR112019018700A2 (pt) | 2017-03-10 | 2020-04-07 | Embera Neurotherapeutics Inc | composições farmacêuticas e seus usos |
| AU2018275552B2 (en) | 2017-06-01 | 2022-01-20 | Bristol-Myers Squibb Company | Substituted nitrogen containing compounds |
| CN112599420B (zh) * | 2020-12-28 | 2022-08-26 | 绵阳惠科光电科技有限公司 | 一种铟镓锌氧基多层结构薄膜晶体管的制备方法 |
| WO2024235165A1 (zh) * | 2023-05-12 | 2024-11-21 | 南京明德新药研发有限公司 | 含氮杂环类化合物及其应用 |
| WO2025024488A2 (en) * | 2023-07-27 | 2025-01-30 | Mineralys Therapeutics, Inc. | Methods of treating hypertension with a combination of lorundrostat and two or more anti-hypertensive medications |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2951135A1 (de) | 1979-12-19 | 1981-06-25 | Hoechst Ag, 6230 Frankfurt | Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
| DE3347565A1 (de) | 1983-12-30 | 1985-07-11 | Thomae Gmbh Dr K | Neue phenylessigsaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| JPS61191681A (ja) * | 1985-02-21 | 1986-08-26 | Fujisawa Pharmaceut Co Ltd | ４−イミダゾリン−２−オン誘導体 |
| US5120712A (en) | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
| US5118666A (en) | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
| CN1029479C (zh) * | 1989-11-08 | 1995-08-09 | 山之内制药株式会社 | 新型苯并噁嗪衍生物的制备方法 |
| EP0512042B1 (en) | 1990-01-24 | 1998-04-08 | BUCKLEY, Douglas I. | Glp-1 analogs useful for diabetes treatment |
| AU654331B2 (en) | 1991-03-30 | 1994-11-03 | Kissei Pharmaceutical Co. Ltd. | Succinic acid compounds |
| RU2086544C1 (ru) | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| KR100496720B1 (ko) | 1991-06-21 | 2006-01-27 | 닥터.칼토매게엠베하 | (s)(+)-2-에톡시-4[n-[1-(2-피페리디노페닐)-3-메틸-1-부틸]아미노카보닐메틸]-벤조산을함유하는당뇨병치료제 |
| EP0618803A4 (en) | 1991-12-19 | 1995-03-22 | Southwest Found Biomed Res | POLYPEPTIDE INHIBITING PROTEIN TRANSFER TO CHOLESTERYL ESTERS, ANTIBODIES AGAINST SYNTHETIC POLYPEPTIDE AND ANTI-ATHEROSCLEROSIS PROPHYLACTIC AND THERAPEUTIC TREATMENTS. |
| US5508272A (en) | 1993-06-15 | 1996-04-16 | Bristol-Myers Squibb Company | Compounds containing a fused bicycle ring and processes therefor |
| IL111785A0 (en) | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
| US5705483A (en) | 1993-12-09 | 1998-01-06 | Eli Lilly And Company | Glucagon-like insulinotropic peptides, compositions and methods |
| US5512549A (en) | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| TW313568B (OSRAM) | 1994-12-20 | 1997-08-21 | Hoffmann La Roche | |
| DE122010000020I1 (de) | 1996-04-25 | 2010-07-08 | Prosidion Ltd | Verfahren zur Senkung des Blutglukosespiegels in Säugern |
| TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
| US6197786B1 (en) | 1998-09-17 | 2001-03-06 | Pfizer Inc | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
| GT199900147A (es) | 1998-09-17 | 1999-09-06 | 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas. | |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| AU4483000A (en) | 1999-04-23 | 2000-11-10 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) |
| US6677341B2 (en) | 1999-09-23 | 2004-01-13 | Pharmacia Corporation | (R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
| WO2003086467A1 (en) | 2002-04-08 | 2003-10-23 | Smithkline Beecham Corporation | Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor |
| JP2007524596A (ja) | 2003-02-28 | 2007-08-30 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 共結晶医薬組成物 |
| US9259390B2 (en) | 2003-08-13 | 2016-02-16 | The University Of Houston System | Parenteral and oral formulations of benzimidazoles |
| AU2005214258A1 (en) * | 2004-02-23 | 2005-09-01 | Dainippon Sumitomo Pharma Co., Ltd. | Novel heterocyclic compound |
| ATE402180T1 (de) | 2004-03-26 | 2008-08-15 | Lilly Co Eli | Verbindungen zur behandlung von dyslipidemie |
| UA90269C2 (ru) | 2004-04-02 | 2010-04-26 | Мицубиси Танабе Фарма Корпорейшн | Тетрагидрохинолиновые производные и способ их получения |
| WO2006066133A2 (en) | 2004-12-16 | 2006-06-22 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| MX2007013450A (es) | 2005-04-29 | 2008-01-21 | Wyeth Corp | Procedimniento de preparacion de oxindoles y tio-oxindoles 3,3-disustituidos. |
| PE20070220A1 (es) | 2005-07-29 | 2007-03-19 | Wyeth Corp | Proceso para la sintesis de moduladores del receptor de progesterona |
| SG165315A1 (en) * | 2005-08-25 | 2010-10-28 | Schering Corp | Alpha2c adrenoreceptor agonists |
| US8436035B2 (en) * | 2006-12-18 | 2013-05-07 | Novartis Ag | Organic compounds |
| US20090176778A1 (en) | 2007-08-10 | 2009-07-09 | Franz Ulrich Schmitz | Certain nitrogen containing bicyclic chemical entities for treating viral infections |
| DE102008022221A1 (de) | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
| AR072297A1 (es) | 2008-06-27 | 2010-08-18 | Novartis Ag | Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona. |
| US8778972B2 (en) | 2009-05-15 | 2014-07-15 | Novartis Ag | 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or CYP11B1 |
| MY184008A (en) | 2009-05-15 | 2021-03-17 | Novartis Ag | Aryl pyridine as aldosterone synthase inhibitors |
| ES2430088T3 (es) | 2009-05-15 | 2013-11-18 | Novartis Ag | Derivados de benzoxazolona como inhibidores de aldosterona sintasa |
-
2010
- 2010-05-12 ES ES10720398T patent/ES2430088T3/es active Active
- 2010-05-12 CA CA2761853A patent/CA2761853A1/en not_active Abandoned
- 2010-05-12 MX MX2011012199A patent/MX2011012199A/es not_active Application Discontinuation
- 2010-05-12 JP JP2012510286A patent/JP5654572B2/ja not_active Expired - Fee Related
- 2010-05-12 EA EA201101621A patent/EA201101621A1/ru unknown
- 2010-05-12 AU AU2010247391A patent/AU2010247391A1/en not_active Abandoned
- 2010-05-12 WO PCT/EP2010/056529 patent/WO2010130773A2/en not_active Ceased
- 2010-05-12 KR KR1020117029906A patent/KR20120036850A/ko not_active Withdrawn
- 2010-05-12 BR BRPI1012852A patent/BRPI1012852A2/pt not_active IP Right Cessation
- 2010-05-12 CN CN201080031607.6A patent/CN102459247B/zh not_active Expired - Fee Related
- 2010-05-12 EP EP10720398.6A patent/EP2430018B1/en not_active Not-in-force
- 2010-05-12 US US13/319,768 patent/US8455522B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012526769A5 (OSRAM) | ||
| JP7376556B2 (ja) | 心臓状態に対するピリミジンジオン化合物 | |
| JP2021038263A (ja) | 治療上活性な化合物およびそれらの使用方法 | |
| PT2007752E (pt) | Benzoimidazol-2-il pirimidinas e pirazinas como moduladores do receptor de histamina h4 | |
| CN110698415B (zh) | 一种肌球蛋白抑制剂及其制备方法和用途 | |
| US9745282B2 (en) | Indoline compounds as aldosterone synthase inhibitors | |
| DK3172212T3 (en) | Aldosterone synthase inhibitors. | |
| ES2802977T3 (es) | Compuesto para la modulación inmunológica, uso del mismo y composición farmacéutica que lo comprende | |
| KR102487051B1 (ko) | 아미노카보닐카바메이트 화합물 | |
| BR112017002873B1 (pt) | Processo para preparar intermediários sintéticos para preparar derivados de tetra-hidroquinolina | |
| JP5749410B2 (ja) | ジヒドロピロロ［１，２−ｃ］イミダゾリルアルドステロンシンターゼまたはアロマターゼ阻害薬の新たな形態および塩 | |
| CA3103770A1 (en) | Phenyl and pyridinyl substituted imidazoles as modulators of roryt | |
| JP2017500321A5 (OSRAM) | ||
| AU2020207051A1 (en) | Metalloenzyme inhibitor compounds | |
| PT1487424E (pt) | 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-il-amino)fenil]-benzamida para o tratamento doenças mediadas por ang ii | |
| JP4950170B2 (ja) | 新規フェニルアセテート誘導体またはその薬学的に許容可能な塩、その製造方法及びそれを有効成分として含むｔ−型カルシウムイオンチャンネルの活性によって誘発される疾患の予防または治療用組成物 | |
| US9278093B2 (en) | Aldosterone synthase inhibitors | |
| JP5859115B2 (ja) | １，４−ジヒドロピリジン−３，５−ジカルボキシラート誘導体、その調製方法及びその使用 | |
| JP6839097B2 (ja) | 医薬 | |
| JP2012505225A5 (OSRAM) | ||
| WO2009088063A1 (ja) | 医薬組成物、医薬組成物製造のための２－イミノピロリジン誘導体の使用および心疾患の治療用または改善用キット | |
| KR20240130685A (ko) | 화합물, 안지오텐신 ii 타입 1 수용체 길항제 및 의약 조성물 | |
| TW201000097A (en) | Medicament for the prophylaxis or treament of hypertension | |
| EP2934144B1 (en) | Indazole compounds as aldosterone synthase inhibitors | |
| NZ766570A (en) | Pyrimidinones as factor xia inhibitors |